Prognostic Factors in Elderly Patients with Diffuse Large B-Cell Lymphoma and Their Treatment Results
Süleyman Cem AdiyamanInci AlacaciogluAyça Erşen DanyeliDoğuş TürkyılmazOmur Gokmen SevindikFatih DemirkanÖzden PişkinMehmet Ali ÖzcanBülent ÜndarSermin ÖzkalGuner Hayri OzsanPublished in: Turkish journal of haematology : official journal of Turkish Society of Haematology (2019)
According to our findings, we think that being able to complete standard R-CHOP therapy is vital for the survival rate of elderly DLBCL patients.